Dr. M

Global Wellness Leader Dr. M’s Strategic Investment in American Stem Cell Pioneer “Stemedica”

Global Wellness Leader Dr. M has always been on a lookout for new technologies and scientific discoveries that can improve community wellbeing and quality of human life. His visionary investments in latest technologies in the field of office automation, mobility healthcare and wellness have built a positive ecosystem that helped businesses and consumers leverage technologies that enhance productivity. In pursuance of his lifelong mission, Global Wellness Leader Dr. M, in 2014 made another strategic investment in Stemedica Cell Technologies – a US based organisation that is one of the pioneers of Stem Cell Therapy in the world. Stemedica is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. To test the efficacy of regenerative medicine in reversing disease and sustaining optimum health, Global Wellness Leader Dr. M, undertook a rigorous and carefully administered stem cell procedure.


Stem cells are the raw materials of the human body. They are the only cells that can generate new types of cells. It is because of this quality that Stem cell therapy is often regarded as the holy grail for human longevity, wellbeing and health span. From aesthetics to treatment of chronic diseases, stem cell therapy can potentially revolutionise the global healthcare industry. Stem cell therapy has been known to alleviate – and in some cases – mitigate conditions such as hypertension, diabetes, Alzheimer’s, Parkinson’s, traumatic spinal cord injury, stroke, severe burns, rheumatoid arthritis, heart disease, hearing loss, retinal disease and Huntington’s amongst others. Being one of the leading companies working in the field of cell therapy, Stemedica is globally renowned for developing a proprietary technology to produce “best-in-class” clinical grade, ischemic- tolerant, allogeneic adult progenitor cell products which play an important role in the treatment of ischemic stroke and Alzheimer’s disease..

The global stem cell therapy market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period. Market growth is driven mainly by factors such as rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells. High growth potential in emerging markets is expected to pave the way for numerous opportunities for the key players in the sector. Global Wellness Leader, Dr. M has expressed confidence in the industry, “The human body is a warehouse of opportunity and potential. Scientific innovation has enabled us to leverage our strengths to live, work, think and feel better with renewed energy and focus. For me stem cells and regenerative medicine represent an opportunity to live a productive life beyond 100 years of age – I want to make this opportunity accessible to everyone.”

Stem cell therapy and research within this industry can have a significant impact on human life. As an industry, regenerative medicine is seeing extensive investment spurring more in-depth research and therapeutic treatments that can disseminated globally and are cost effective. Global Wellness Leader Dr. M, with his strategic investment, aims to bring the latest stem cell and wellness technologies to India to help people live happy and healthy lives beyond 100 years.